Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

AstraZeneca, Isis Pharmaceuticals to Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases

August 3, 2015 9:54 am | News | Comments

Isis Pharmaceuticals, Inc. and AstraZeneca today announced a strategic collaboration to discover and develop antisense therapies for cardiovascular, metabolic and renal diseases. The new collaboration builds on a broad existing relationship between the two companies and supports AstraZeneca's strategic approach in these therapeutic areas using novel RNA-targeted treatments. Read more...


New Hope In Old Vaccines

August 3, 2015 9:52 am | by Harvard University | News | Comments

Harvard Stem Cell Institute (HSCI) researchers at Massachusetts Eye and Ear (MEE) have reconstructed an ancient virus that is highly effective at delivering gene therapies to the liver, muscle, and retina. Read more...


Lawsuit Accuses CVS of Overcharging for Generic Drugs

August 3, 2015 9:41 am | by Sudhin Thanawala | News | Comments

Health Corp. deliberately overcharged some pharmacy customers for generic drugs by submitting claims to their insurance companies at inflated prices, according to a lawsuit filed Thursday in federal court in San Francisco. Read more...


New Chlamydia Vaccine Uses Synthetic Biology

August 3, 2015 9:28 am | News | Comments

Chlamydia is one of the most common sexually transmitted infections in the world. Read more...


CDC's Top Modeler Courts Controversy with Disease Estimate

August 3, 2015 9:21 am | by Mike Stobbe, AP Medical Writer | News | Comments

Last fall, when Martin Meltzer calculated that 1.4 million people might contract Ebola in West Africa, the world paid attention. Read more...


Merck's Ebola Vaccine Declared 'Highly Effective' in Clinical Trial

August 3, 2015 9:11 am | by Ryan Bushey, Associate Editor | Articles | Comments

Scientists taking part in the investigation tested the drug on 4,000 people with close ties to Ebola patients. Read more...


Roche Probed in Romanian Graft Case

August 3, 2015 8:34 am | by Alison Mutler, Associated Press | News | Comments

Swiss pharmaceuticals company Roche confirmed Friday it is being investigated by anti-corruption prosecutors looking for evidence that drug companies offered doctors vacations and other incentives in exchange for prescribing cancer drugs. Read more...


Novartis' Revolade Recommended for EU Approval to Treat Severe Blood Disorder

August 3, 2015 8:34 am | News | Comments

Treatment of SAA is focused on increasing a patient's blood cell count. Read more...


Testing for Malaria Reduces Overprescription by More than 70%

August 3, 2015 8:33 am | by London School of Hygiene & Tropical Medicine | News | Comments

Using malaria rapid diagnostic tests in registered drug shops in a highly endemic region in Uganda substantially reduced overdiagnosis of malaria, improving the use of valuable malaria drugs. Read more...


FDA Warns of Drug Name Mix-Ups

July 31, 2015 10:06 am | by Marley Jay, AP Business Writer | News | Comments

The Food and Drug Administration said Thursday that some doctors and pharmacies are getting confused by the similar names of an antidepressant and a blood-thinning medicine. Read more...


Seniors Get Mental Health Drugs at Twice the Rate of Younger Adults

July 31, 2015 10:02 am | by University of Michigan | News | Comments

Older Americans receive prescriptions for mental health medications at more than twice the rate that younger adults do, a new study finds. Read more...


Scientists Receive $1.4M to Study Drug Candidates for Neurological Disorders, Other Diseases

July 31, 2015 9:51 am | by The Scripps Research Institute | News | Comments

The project involves studying what are known as RORs (retinoic acid receptor-related orphan receptors). Read more...


Amgen Hikes 2015 Forecast After 2Q Increase in Profit, Sales

July 31, 2015 9:39 am | by Linda A. Johnson, AP Business Writer | News | Comments

Amgen shares jumped in extended trading after the maker of osteoporosis drug Prolia easily beat Wall Street's second-quarter profit expectations and hiked its 2015 financial forecast. Read more...


Beyond Pills: Designing a Winning Delivery Strategy for the New Era of Biologics

July 31, 2015 9:32 am | by Nurry Hong, Managing Director; Sue St. Sure, Managing Director; and Max Cambras, Life Sciences Expert, Manager, of L.E.K. Consulting | Articles | Comments

With the rise of biologics, drug delivery presents new challenges as many companies are still taking a fragmented approach, resulting in delayed (or suboptimal) product launches and life cycle management. The problem is that it’s extremely difficult, if not impossible, to fix drug delivery challenges after the fact, so companies need a clear strategy in advance. Read more...


Type 2 Diabetes Mellitus Treatment Market Value Will Reach $39B by 2021

July 31, 2015 9:31 am | by Fiona Chisholm, Associate Analyst, GBI Research | Articles | Comments

More recently approved drug classes have already achieved considerable uptake and are expected to increase their market share over the forecast period. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.